Dose intensity in cancer chemotherapy.
作者信息
Dodwell D J, Gurney H, Thatcher N
机构信息
CRC Dept of Medical Oncology, Christie Hospital, Manchester, UK.
出版信息
Br J Cancer. 1990 Jun;61(6):789-94. doi: 10.1038/bjc.1990.178.
Abstract
摘要
相似文献
1
Dose intensity in cancer chemotherapy.
Br J Cancer. 1990 Jun;61(6):789-94. doi: 10.1038/bjc.1990.178.
2
Evaluation of the use of high-dose cytoreduction with autologous marrow rescue in various malignancies.
Transplantation. 1986 Jan;41(1):4-20. doi: 10.1097/00007890-198601000-00002.
3
Chemotherapy dose intensity in small cell lung cancer.
Lung Cancer. 1994 Mar;10 Suppl 1:S175-85. doi: 10.1016/0169-5002(94)91680-2.
4
[Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].
Gan To Kagaku Ryoho. 2001 Oct;28(10):1352-6.
5
Diseases desperate grown.
J Natl Cancer Inst. 2008 Apr 16;100(8):520-1. doi: 10.1093/jnci/djn082. Epub 2008 Apr 8.
6
High-dose chemotherapy in lung cancer.
Chest. 1989 Jul;96(1 Suppl):66S-68S. doi: 10.1378/chest.96.1_supplement.66s.
7
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
Semin Oncol. 2004 Dec;31(6 Suppl 14):25-33. doi: 10.1053/j.seminoncol.2004.11.005.
8
Should maintenance chemotherapy be used to treat small cell lung cancer?
Eur J Cancer. 1998 Jul;34(8):1148-55. doi: 10.1016/s0959-8049(98)00081-1.
9
[Treatment of cancer in the elderly--cancer chemotherapy].
Gan To Kagaku Ryoho. 1990 Apr;17(4 Pt 2):852-8.
10
Dose-intensive therapy for small cell lung cancer.
Chest. 1995 Jun;107(6 Suppl):261S-266S. doi: 10.1378/chest.107.6_supplement.261s.
引用本文的文献
1
Management of chemotherapy dose intensity for metastatic colorectal cancer.
Oncol Lett. 2022 May;23(5):141. doi: 10.3892/ol.2022.13261. Epub 2022 Mar 11.
2
An open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors.
J Vet Intern Med. 2015 Mar-Apr;29(2):620-5. doi: 10.1111/jvim.12557.
3
The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
Arch Orthop Trauma Surg. 1996;115(2):68-70. doi: 10.1007/BF00573443.
4
[Janus-faced character of chemotherapy: a comment on the Abel theses].
Klin Wochenschr. 1991 Jan 4;69(1):49-51. doi: 10.1007/BF01649059.
5
New perspectives in lung cancer. 4. Haematopoietic growth factors and lung cancer treatment.
Thorax. 1992 Feb;47(2):119-26. doi: 10.1136/thx.47.2.119.
6
Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples.
Cancer Chemother Pharmacol. 1992;30(3):199-206. doi: 10.1007/BF00686312.
本文引用的文献
1
Methotrexate treatment of squamous-cell head and neck cancers: dose-response evaluation.
Br Med J (Clin Res Ed). 1981 Feb 21;282(6264):600-2. doi: 10.1136/bmj.282.6264.600.
2
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
J Clin Oncol. 1983 Feb;1(2):146-53. doi: 10.1200/JCO.1983.1.2.146.
3
Increasing the therapeutic response rates to anticancer drugs by applying the basic principles of pharmacology.
Cancer. 1984 Sep 15;54(6 Suppl):1160-7. doi: 10.1002/1097-0142(19840915)54:1+<1160::aid-cncr2820541312>3.0.co;2-p.
4
The importance of dose intensity in chemotherapy of metastatic breast cancer.
J Clin Oncol. 1984 Nov;2(11):1281-8. doi: 10.1200/JCO.1984.2.11.1281.
5
The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival.
Cancer Treat Rep. 1983 Jun;67(6):519-26.
6
Increased therapeutic index of weekly doxorubicin in the therapy of non-small cell lung cancer: a prospective, randomized study.
J Clin Oncol. 1984 Mar;2(3):207-14. doi: 10.1200/JCO.1984.2.3.207.
7
Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.
Cancer. 1984 Mar 1;53(5):1029-35. doi: 10.1002/1097-0142(19840301)53:5<1029::aid-cncr2820530503>3.0.co;2-z.
8
Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo.
J Natl Cancer Inst. 1966 Aug;37(2):233-45.
9
Drug dosage and remission duration in childhood lymphocytic leukemia.
Cancer. 1971 Feb;27(2):247-56. doi: 10.1002/1097-0142(197102)27:2<247::aid-cncr2820270202>3.0.co;2-c.
10
Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer.
Breast Cancer Res Treat. 1985;5(2):95-115. doi: 10.1007/BF01805984.
Zotero 插件